lifestyle.marketresearchjournals.com

Author: Brainomix Limited

Brainomix e-Lung AI Imaging Technology Selected as Co-Primary Endpoint in Boehringer Ingelheim Phase 3 Clinical Trial in Pulmonary Fibrosis

January 20, 2026
Brainomix AI Technology Reveals Efficacy of Novel Neuroprotective Drug Candidate in Severe Acute Ischemic Stroke Patients

December 20, 2025
Brainomix Announces New Study Published in Lancet Digital Health Demonstrating Impact of Brainomix 360 Stroke to Increase Endovascular Thrombectomy Rates

December 3, 2025
Brainomix Joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation

November 2, 2025